Prediction of progressive pulmonary fibrosis in patients with anti-synthetase syndrome-associated interstitial lung disease.

Hongyan Fu Ziyao Zheng Zhenping ZhangYanjuan YangJieda Cui Zhaojun Wang Jing Xue Shuhong ChiMengshu CaoJuan Chen

Published in: Clinical rheumatology (2023)

Positive non-Jo-1 antibodies, NLR, and serum KL-6 are independent risk factors for PPF in patients with ASS-ILD. Monitoring these markers can potentially predict PPF in this group of patients. Key Points • Positive non-Jo-1 antibodies, NLR, and serum KL-6 are independent risk factors associated with PPF in patients with ASS-ILD. • Monitoring non-Jo-1 antibodies, NLR, and serum KL-6 can potentially predict PPF in patients with ASS-ILD.

Keyphrases

interstitial lung disease
systemic sclerosis
rheumatoid arthritis
idiopathic pulmonary fibrosis
pulmonary fibrosis
end stage renal disease
ejection fraction
newly diagnosed
multiple sclerosis
patient reported